Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3016330	du-k	— (—)	642	822	100.00%	Distribution not available
3016330	du-k	mmol/d (mmol/24h)	16	16	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Secondary hypertension

108

136.80

100.94

1.4

1.8

—

Endocrine, nutritional and metabolic diseases

133

137

4.91

46.26

1.4

1.2

89.16

77.51

mmol/24h

—

All chronic kidney diseases

108

242

3.56

30.56

1.3

1.2

—

88.92

—

Chronic kidney disease

147

4.00

21.59

1.3

—

75.50

—

Renal tubulo-interstitial diseases

137

433

2.32

17.73

1.2

1.3

—

78.77

—

Migraine

226

2.93

17.72

1.3

—

74.69

—

Other heart diseases, wide

145

385

2.28

17.22

1.3

80.14

78.83

mmol/24h

—

General symptoms and signs

154

343

2.25

16.82

1.3

96.99

71.27

mmol/24h

—

Headache

104

323

2.49

15.94

1.2

1.3

—

71.27

—

Abnormalities of heart beat

179

3.26

15.83

1.3

1.2

—

95.07

—

Symptoms and signs involving the urinary system

115

375

2.31

15.00

1.3

1.2

85.10

87.47

mmol/24h

—

Persons encountering health services in other circumstances

270

2.72

14.32

1.3

—

80.96

—

Renal failure

228

2.73

13.81

1.3

1.2

—

85.49

—

Type 2 diabetes, wide definition

113

316

2.26

13.37

1.3

1.2

—

84.81

—

Obesity related asthma

221

2.81

12.87

1.3

1.2

—

86.64

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

191

2.83

11.42

1.3

1.2

—

89.32

—

Glucagon-like peptide-1 (GLP-1) analogues

191

2.83

11.42

1.3

1.2

—

89.32

—

Disorders resulting from impaired renal tubular function

13.00

10.65

1.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

130

440

1.94

10.59

1.3

96.30

70.86

mmol/24h

—

Asthma, unspecified (mode), excluding more controls

240

2.33

10.33

1.3

—

85.88

—

Intestinal infectious diseases

132

519

1.89

10.33

1.4

1.3

—

80.34

—

Diarrhoea and gastroenteritis of presumed infectious origin

101

440

2.05

10.30

1.4

1.3

—

81.35

—

Hypothyroidism, other/unspecified

124

419

1.95

10.28

1.3

96.30

71.21

mmol/24h

—

Asthma, excluding more controls

105

255

2.12

10.20

1.4

1.3

—

85.88

—

Other diseases of upper respiratory tract

143

398

1.87

10.03

1.2

1.3

75.42

86.95

mmol/24h

—

Disorders of the thyroid gland

130

445

1.90

9.97

1.3

97.03

71.21

mmol/24h

—

Asthma, unspecified (mode)

251

2.27

9.96

1.3

—

86.25

—

Migraine with aura

124

3.15

9.96

1.3

1.2

—

84.87

—

Asthma (mode)

107

272

2.07

9.89

1.3

—

86.25

—

Other antidepressants

130

350

1.90

9.45

1.3

84.80

83.19

mmol/24h

—

Asthma

106

269

2.03

9.37

1.3

—

86.25

—

Epilepsy

140

2.92

9.25

1.2

1.3

—

90.14

—

Other arrhythmias

312

2.08

8.99

1.4

1.3

88.95

88.04

mmol/24h

—

Fever of other and unknown origin

289

2.19

8.82

1.3

—

81.59

—

Other septicaemia

214

2.43

8.56

1.3

—

88.13

—

Other septicaemia, including avohilmo

215

2.40

8.39

1.3

—

88.13

—

Adverse effects, not elsewhere classified

111

3.07

8.37

1.1

1.3

—

96.20

—

Acute tubulo-interstitial nephritis

350

2.03

8.31

1.2

—

84.04

—

Use of pramipexole

117

3.00

8.28

1.2

—

87.32

—

Hyperkalaemia

11.72

8.07

1.1

—

Hyperlipidaemia, other/unspecified

145

2.67

8.06

1.2

—

93.11

—

Lower back pain or/and sciatica

141

509

1.72

7.97

1.2

1.3

77.13

79.71

mmol/24h

—

Asthma (only as main-diagnosis), excluding more controls

255

2.00

7.96

1.3

—

85.88

—

Mouth breathing

255

2.27

7.93

1.3

1.2

—

88.36

—

Irritable bowel syndrome

165

2.61

7.90

1.3

1.2

—

96.21

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

117

385

1.80

7.66

1.4

1.2

—

81.46

—

Asthma (only as main-diagnosis)

269

1.93

7.43

1.3

—

86.25

—

Asthma (diagnoses ohter than nonallergic)

114

527

1.75

7.19

1.3

—

78.89

—

Persons encountering health services in other circumstances, wide

143

437

1.68

7.18

1.3

85.97

80.91

mmol/24h

—

Selective serotonin reuptake inhibitors

119

350

1.77

7.12

1.3

86.80

83.19

mmol/24h

—

Retention of urine

138

2.52

7.09

1.2

1.3

—

81.79

—

Other systemic involvement of connective tissue (FG)

137

2.65

7.04

1.1

1.2

—

91.09

—

Other and unspecified effects of external causes

183

2.41

6.89

1.1

1.3

—

96.20

—

Dorsalgia

121

369

1.74

6.88

1.3

85.36

79.70

mmol/24h

—

294

2.06

6.59

1.3

1.2

—

84.53

—

IgA nephropathy (IgA glomerulonephritis)

12.35

6.59

1.7

1.3

—

Abdominal and pelvic pain

116

337

1.73

6.43

1.3

79.44

76.87

mmol/24h

—

Diabetes, insulin treatment (Kela reimbursement)

122

435

1.67

6.22

1.4

1.2

—

82.87

—

Convulsions, not elsewhere classified

125

2.61

6.13

1.2

1.3

—

78.28

—

L04AA Selective immunosuppressants

127

2.60

6.11

1.2

1.3

—

89.82

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

162

2.38

5.99

1.3

—

73.69

—

Other systemic involvement of connective tissue

153

2.42

5.92

1.1

1.2

—

84.96

—

Migraine without aura

2.79

5.71

1.5

1.2

—

87.90

—

Other and unspecified myopathies

5.18

5.69

1.2

—

Dialysis

8.51

5.56

1.1

1.3

—

STROKE

222

1.94

5.52

1.2

—

84.96

—

Insulin medication

311

1.84

5.32

1.4

1.2

—

89.11

—

Other/unspecified dorsalgia

223

2.08

5.30

1.4

1.3

—

92.01

—

Acute upper respiratory infections of multiple and unspecified sites

418

1.68

5.25

1.2

1.3

—

80.36

—

Symptoms and signs involving the digestive system and abdomen

110

337

1.64

5.09

1.3

90.91

76.87

mmol/24h

—

Other functional intestinal disorders

253

1.94

4.97

1.2

—

95.41

—

Diseases of liver

219

2.06

4.95

1.3

—

87.33

—

Implicit bacterial Sepsis, including avohilmo

220

1.97

4.90

1.1

1.3

—

86.21

—

Diverticular disease of intestine

282

1.74

4.86

1.2

79.80

87.49

mmol/24h

—

Obesity, other/unspecified

221

2.04

4.84

1.2

1.3

—

87.33

—

Other and unspecified iron deficiency

194

2.11

4.83

1.4

1.2

—

88.70

—

Other dorsopathies, not elsewhere classified

113

370

1.59

4.70

1.3

87.16

79.70

mmol/24h

—

Dorsopathies

115

370

1.57

4.62

1.3

87.16

79.70

mmol/24h

—

Asthma, hospital admissions , main diagnosis only

540

1.58

4.43

1.3

—

78.89

—

Implicit bacterial Sepsis

195

1.98

4.38

1.2

1.3

—

86.21

—

Other dialysis

7.55

4.36

1.1

1.3

—

Other general symptoms and signs

7.45

4.32

1.1

1.8

—

Asthma, hospital admission 2, infections

402

1.70

4.30

1.3

—

85.48

—

Asthma-related infections

402

1.70

4.30

1.3

—

85.48

—

Carcinoma in situ of skin of upper limb, including shoulder

11.74

4.28

1.0

1.3

—

Unspecified haematuria

198

1.93

4.26

1.4

1.3

—

79.26

—

Insulin, fast-acting or short human

222

1.94

4.07

1.5

1.3

—

91.18

—

Insulin, combination of fast acting with intermediate-acting or long-acting

372

1.68

4.07

1.4

1.2

—

88.40

—

Viral and other specified intestinal infections

113

2.33

4.07

1.2

1.3

—

90.85

—

Other and unspecified dermatitis

369

1.71

4.00

1.3

—

79.75

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

197

1.98

3.95

1.3

—

89.27

—

Abnormal findings on examination of blood, without diagnosis

267

1.80

3.94

1.3

1.2

—

89.36

—

Insulin, fast-acting

218

1.93

3.93

1.5

1.3

—

89.36

—

Insulin, intermediate and long-acting

343

1.72

3.92

1.4

1.2

—

89.28

—

Diseases of the ear and mastoid process

131

448

1.47

3.86

1.4

1.3

77.88

79.25

mmol/24h

—

Nerve, nerve root and plexus disorders

121

493

1.47

3.82

1.3

85.58

78.15

mmol/24h

—

Drug-induced adrenocortical insufficiency

8.82

3.78

1.1

1.9

—

Retinal haemorrhage

8.80

3.77

2.0

1.4

—

Hypertrophic cardiomyopathy

5.65

3.66

1.1

1.3

—

Noninfective enteritis and colitis

320

1.72

3.59

1.3

—

85.49

—

Paralytic ileus and intestinal obstruction

136

2.13

3.59

1.3

—

95.49

—

Fungal Sepsis

7.80

3.56

1.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

120

437

1.46

3.54

1.2

1.3

77.63

80.91

mmol/24h

—

Suppurative and unspecified otitis media

219

1.82

3.51

1.5

1.3

—

82.68

—

Contact with nonpowered hand tool

5.32

3.51

1.6

1.3

—

Triptan medication for migraine, min. 3 purchases

330

1.61

3.47

1.4

1.3

79.40

75.10

mmol/24h

—

Other noninfective gastroenteritis and colitis

125

2.16

3.46

1.3

1.2

—

89.82

—

Disorders of skin appendages

362

1.65

3.40

1.3

—

83.94

—

Suicide or other Intentional self-harm

153

2.03

3.39

1.3

—

96.20

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

101

2.28

3.35

1.2

1.3

—

97.62

—

Small fibre neuropathy

5.75

3.34

1.3

—

Other aneurysm

4.75

3.24

1.2

1.3

—

Any mental disorder

119

415

1.44

3.23

1.3

88.49

70.23

mmol/24h

—

Dronedarone medication

6.40

3.19

1.0

1.2

—

Personality disorders, excluding more controls

150

2.00

3.16

1.2

1.3

—

73.69

—

Calculus of lower urinary tract

4.51

3.11

1.6

1.2

—

Hypocalcemia

5.87

3.02

1.4

1.2

—

Carrier of infectious disease

5.86

3.02

1.6

1.7

—

Type 1 diabetes

126

2.06

3.00

1.7

1.3

—

97.17

—

Glaucoma-related operations

4.30

2.99

1.4

1.2

—

Viral and other specified intestinal infections, including avohilmo

168

1.89

2.98

1.2

1.3

—

91.49

—

Cushing syndrome

10.09

2.98

1.4

—

Eosinophilic disease (BM)

10.07

2.98

1.4

1.0

—

Eosinophilia

10.07

2.98

1.4

1.0

—

Other cataract

187

1.75

2.98

1.3

—

88.86

—

Care involving use of rehabilitation procedures

425

1.52

2.94

1.3

—

74.64

—

Retinal vascular occlusion

2.83

2.91

1.4

1.2

—

Retinal vascular disorders

2.83

2.91

1.4

1.2

—

Acute pharyngitis

2.32

2.91

1.4

1.3

—

91.03

—

Internal derangement of knee

255

1.71

2.89

1.3

1.2

—

103.33

—

Other bacterial intestinal infections, including avohilmo

129

2.02

2.85

1.2

—

92.45

—

Disorders of choroid and retina

399

1.47

2.83

1.4

1.2

—

86.04

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

116

2.07

2.82

1.1

1.3

—

74.40

—

Delirium, not induced by alcohol and other psychoactive substances

2.64

2.77

1.1

1.2

—

Nontoxic goitre/thyroid nodule

166

1.87

2.75

1.2

—

85.82

—

Vascular disorders of the intestines

4.22

2.67

1.1

1.3

—

Osteoporosis

134

1.92

2.66

1.3

1.2

—

73.32

—

Other and unspecified vascular occlusions

3.15

2.64

1.5

1.2

—

Use of selegiline

4.68

2.59

1.4

1.3

—

Other retinal disorders

313

1.53

2.59

1.4

1.2

—

86.64

—

Poisoning by medicine

134

1.94

2.59

1.2

1.3

—

96.20

—

Type 1 diabetes, wide definition, subgroup 1

107

2.06

2.55

1.7

1.3

—

97.00

—

Ankylosing hyperostosis [Forestier]

7.20

2.55

1.0

1.1

—

Panhypopituitarism

7.19

2.55

1.6

1.3

—

Paraplegia, diplegia of upper limbs

7.18

2.55

1.4

1.1

—

Disorders of speech understanding and production

5.36

2.50

1.5

1.1

—

Pollen allergy

127

1.94

2.49

1.2

1.3

—

99.48

—

Gingival hyperplasia

4.39

2.47

1.1

1.3

—

Poisoning by drugs, medicaments and biological substances

151

1.86

2.46

1.1

1.3

—

96.20

—

Other extrapyramidal and movement disorders in other diseases

137

1.90

2.44

1.5

1.2

—

89.82

—

Sequelae of external causes of morbidity and mortality

152

1.84

2.41

1.2

1.3

—

85.80

—

Biological medication for rheuma

103

2.04

2.41

1.5

1.4

—

97.62

—

Other diseases of spinal cord

5.02

2.40

1.3

—

Benign neoplasm of other and unspecified sites

5.02

2.40

1.7

1.2

—

Traumatic subarachnoid haemorrhage

5.01

2.40

1.0

1.1

—

Implicit fungal Sepsis

6.26

2.37

1.2

1.4

—

Other and unspecified glaucoma

3.64

2.36

1.3

1.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

278

1.60

2.36

1.4

1.3

—

85.66

—

Extrapyramidal and movement disorders

236

1.65

2.34

1.4

1.2

—

85.49

—

Other disorders starting during childhood or adolecense, excluding more controls

4.78

2.31

1.3

1.6

—

Embedded and impacted teeth

154

0.37

2.30

1.4

1.3

—

89.27

—

Type 1 diabetes, wide definition

112

1.96

2.29

1.7

1.3

—

97.00

—

Urethral stricture

4.62

2.27

1.3

—

Other female pelvic inflammatory diseases

2.10

2.22

1.3

1.2

—

88.82

—

Benign neoplasm: Skin of lower limb, including hip

5.57

2.21

1.0

1.3

—

Simple and mucopurulent chronic bronchitis

5.57

2.21

1.4

1.1

—

Allergic asthma (mode), excluding more controls

132

1.85

2.19

1.3

—

89.52

—

Combinations of oral blood glucose lowering drugs

158

1.77

2.16

1.3

1.2

—

88.41

—

Other benign neoplasms of skin

234

1.63

2.15

1.2

—

85.50

—

Allergic asthma (mode)

133

1.84

2.15

1.3

—

89.59

—

Cardiodefibrillation

196

1.68

2.12

1.3

1.2

—

82.23

—

Stroke, including SAH

298

1.47

2.12

1.2

1.3

—

85.49

—

Asthma and allergy

2.21

2.10

1.3

—

96.14

—

Osteoporosis with pathological fracture (FG)

3.21

2.09

1.3

—

Secondary polycythaemia

5.02

2.07

1.2

1.1

—

Fall involving bed

5.01

2.07

1.4

1.2

—

Asthma-related pneumonia

205

1.65

2.07

1.3

1.2

—

87.54

—

Asthma, hospital admissions 3, pneumonia

205

1.65

2.07

1.3

1.2

—

87.54

—

Asthma-related pneumonia or sepsis

205

1.65

2.07

1.3

1.2

—

87.54

—

Haemorrhoids and perianal venous thrombosis

190

1.67

2.04

1.3

1.2

—

94.43

—

Other disorders starting during childhood or adolescence

3.96

2.02

1.3

1.5

—

Tumor necrosis factor alpha inhibitors

1.96

1.99

1.5

1.4

—

97.62

—

Ulcerative colitis

133

1.81

1.98

1.3

—

94.13

—

Injuries to the wrist and hand

108

545

1.31

1.95

1.3

84.81

76.78

mmol/24h

—

Childhood asthma (age<16)

2.17

1.94

1.4

1.5

—

96.14

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

402

1.36

1.90

1.2

1.3

84.99

77.23

mmol/24h

—

Triptan medication for migraine, single purchase ok

402

1.36

1.90

1.2

1.3

84.99

77.23

mmol/24h

—

Functional dyspepsia

158

1.71

1.88

1.3

1.2

—

80.90

—

Medical treatment for female infertility

156

0.38

1.88

1.2

1.3

—

86.02

—

Stroke, excluding SAH

279

1.45

1.86

1.2

1.3

—

85.49

—

Inflammatory bowel disease

205

1.61

1.85

1.4

1.3

—

89.33

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

397

1.40

1.84

1.3

1.2

—

84.43

—

Benign neoplasm: Pancreas

4.18

1.82

1.6

1.2

—

Somnolence, stupor and coma

4.17

1.82

1.0

1.2

—

Personality disorders

183

1.64

1.81

1.2

1.3

—

87.70

—

Acute suppurative otitis media

163

1.66

1.80

1.7

1.3

—

89.27

—

Specific development disorders of speech and language

3.07

1.80

1.4

1.5

—

Fracture of neck

3.05

1.80

1.1

1.3

—

Specific development disorders of scholastic skills

4.09

1.79

1.2

2.1

—

Intestinal stricture

184

1.63

1.77

1.2

1.3

—

86.83

—

Disorders of adult personality and behaviour

201

1.59

1.73

1.2

1.3

—

87.70

—

Gout, FINNGEN

146

1.70

1.73

1.4

1.2

—

75.50

—

Lesion of sciatic nerve

3.85

1.71

1.2

—

Inflammatory diseases of female pelvic organs

336

1.36

1.62

1.3

1.2

—

75.83

—

Carcinoma in situ of colon

3.58

1.61

1.8

1.3

—

Other diseases of pericardium

3.58

1.61

1.2

1.1

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

3.57

1.61

1.2

1.6

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.83

1.58

1.1

1.2

—

Sub-endpoint used in defining T1D endpoints

164

1.62

1.58

1.7

1.3

—

94.13

—

Other enthesopathies

191

1.57

1.56

1.2

1.3

—

83.06

—

Oxycodone

183

1.54

1.55

1.3

—

79.41

—

Insomnia

502

1.29

1.54

1.3

88.69

75.39

mmol/24h

—

Alcohol dependence

153

1.64

1.52

1.1

1.3

—

95.49

—

Bicuspidal aortic valve syndrome

3.34

1.52

1.2

1.3

—

Psychiatric diseases

364

1.29

1.52

1.4

1.3

90.23

69.26

mmol/24h

—

Sleep disorders

499

1.28

1.50

1.4

1.3

88.69

75.39

mmol/24h

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

253

1.43

1.48

1.3

1.2

—

85.29

—

Normotensive glaucoma

2.44

1.47

1.1

1.2

—

Carcinoma in situ of other and unspecified digestive organs

3.13

1.44

1.8

1.3

—

Barrett oesophagus

3.13

1.44

1.2

—

Clear cell adenocarcinoma of kidney

2.73

1.43

1.0

1.3

—

Other and unspecified nerve root and plexus disorders, also in other diseases

125

1.68

1.43

1.1

1.3

—

79.26

—

Diseases of middle ear and mastoid

358

1.35

1.38

1.5

1.3

—

82.34

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

267

1.44

1.38

1.1

1.3

—

89.33

—

Other disorders of optic [2nd] nerve and visual pathways

2.61

1.36

1.2

1.4

—

Benign neoplasm of urinary organs

2.94

1.36

1.2

—

Venous thromboembolism

327

1.38

1.34

1.3

1.2

—

84.75

—

Specific personality disorders

159

1.57

1.34

1.2

1.3

—

96.20

—

Atopic dermatitis, strict definition with reimbursement

207

1.49

1.33

1.3

—

87.23

—

Impacted teeth

127

0.47

1.33

1.3

—

90.85

—

Erosion of teeth , including avohilmo

184

1.52

1.31

1.3

—

96.20

—

Deviated nasal septum

184

1.52

1.30

1.1

1.3

—

95.21

—

Chronic gastritis

137

1.61

1.28

1.4

1.3

—

75.96

—

Hypercalcemia

2.78

1.28

1.2

—

Salpingitis and oophoritis

1.72

1.27

1.5

1.2

—

87.02

—

Inflammatory disease of uterus

1.79

1.26

1.3

—

99.48

—

Sequelae of injuries, of poisoning and of other consequences of external causes

138

1.60

1.25

1.2

1.3

—

91.84

—

Sequelae with surgical and medical care as external cause

107

1.68

1.25

1.3

—

89.82

—

Open wound of head

340

1.35

1.24

1.1

1.3

—

90.58

—

Iridocyclitis

123

1.63

1.23

1.1

1.3

—

87.63

—

Stomatitis and related lesions

123

1.63

1.23

1.4

1.3

—

89.82

—

Caries of enamel

554

0.78

1.21

1.2

1.3

65.18

86.97

mmol/24h

—

Acute bronchiolitis

2.36

1.20

1.2

—

Other and unspecified tonsillitis

197

1.43

1.19

1.4

1.3

—

88.48

—

Atopic dermatitis, strict definition

201

1.46

1.17

1.3

—

89.27

—

Pulmonary heart disease

157

1.53

1.16

1.2

—

87.33

—

Laparoscopic right hemicolectomy

2.50

1.15

1.0

1.2

—

L01XX Other antineoplastic agents

2.50

1.15

1.0

1.2

—

Sulfasalazine

174

1.50

1.14

1.5

1.3

—

88.87

—

Malignant neoplasm of digestive organs, including Hilmo

201

0.62

1.14

1.1

1.2

—

80.62

—

All influenza

151

1.52

1.11

1.2

—

87.63

—

Seborrhoeic keratosis

135

1.56

1.11

1.2

1.3

—

88.01

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

2.38

1.09

1.4

1.2

—

Pulmonary embolism

160

1.50

1.08

1.2

1.3

—

87.33

—

Nonorganic sleeping disorders

144

1.53

1.08

1.5

1.3

—

96.20

—

Other obstetric conditions, not elsewhere classified

157

1.41

1.08

1.3

—

81.23

—

Pulmonary heart disease, diseases of pulmonary circulation

177

1.47

1.07

1.2

—

87.33

—

Carcinoma in situ of skin

2.12

1.05

1.0

1.2

—

Injuries to the neck

145

1.52

1.05

1.2

1.3

—

96.20

—

Keratitis

245

1.39

1.05

1.2

1.3

—

89.33

—

Fissure and fistula of anal and rectal regions

138

1.52

1.02

1.4

1.2

—

95.49

—

Retinal detachments and breaks

213

1.41

1.01

1.5

1.2

—

85.49

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

154

1.39

1.00

1.3

—

81.23

—

Non-allergic asthma (mode)

1.62

0.99

1.3

1.2

—

98.06

—

Voice disturbances

156

1.48

0.98

1.4

1.2

—

87.32

—

Benign neoplasm: Colon, unspecified

132

1.52

0.96

1.5

1.2

—

88.85

—

Otitis externa

132

1.52

0.96

1.2

1.3

—

92.45

—

Disorders of sclera, cornea, iris and ciliary body

415

1.28

0.96

1.2

1.3

—

88.40

—

Olecranon bursitis

2.22

0.93

1.0

1.3

—

Injury of muscle and tendon at lower leg level

1.67

0.91

1.1

1.3

—

96.11

—

DVT of lower extremities and pulmonary embolism

251

1.35

0.91

1.3

1.2

—

84.74

—

Use of antiglaucoma preparations and miotics

2.07

0.89

1.2

—

Fracture of skull and facial bones

119

1.51

0.87

1.1

1.4

—

87.63

—

Non-allergic asthma (mode), excluding more controls

102

1.55

0.87

1.3

1.2

—

99.67

—

Squamous cell neoplasms and carcinomas of the skin

1.86

0.87

1.1

1.3

—

Postmenopausal osteoporosis with pathological fracture

2.00

0.87

1.0

1.2

—

Any death

323

0.76

0.86

1.2

—

84.74

—

Maternal care for other conditions predominantly related to pregnancy

149

1.44

0.85

1.3

—

83.09

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1.77

0.85

1.1

1.3

—

Endometriosis ASRM stages 1,2

112

1.52

0.84

1.4

1.2

—

99.48

—

Other and unspecified urticaria

113

1.51

0.82

1.1

1.3

—

97.62

—

ILD, hospital admissions 3, with pneumonia sepsis

1.88

0.81

1.7

1.2

—

Long labour

150

0.62

0.80

1.5

1.3

—

90.73

—

Malignant neoplasm of digestive organs

190

0.68

0.79

1.1

1.2

—

80.62

—

Other diseases of anus and rectum

173

1.38

0.77

1.3

1.2

—

92.57

—

Ischaemic Stroke, excluding all haemorrhages

262

1.26

0.76

1.2

1.3

—

85.49

—

Endometriosis of rectovaginal septum and vagina

1.77

0.76

1.5

1.4

—

Abdominal aortic aneurysm (AAA)

2.16

0.76

1.6

1.2

—

Symptoms and signs involving speech and voice

210

1.33

0.73

1.4

1.2

—

84.09

—

Glaucoma, exfoliation

1.80

0.72

1.0

1.2

—

Nasal polyp

1.52

0.72

1.4

1.3

—

98.57

—

Viral warts, including avohilmo

143

0.63

0.69

1.3

—

96.20

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

203

1.27

0.68

1.2

—

83.78

—

Degeneration of macula and posterior pole

211

1.28

0.68

1.2

—

77.78

—

Other puerperal infections

1.63

0.66

1.0

1.4

—

99.48

—

Phlebitis and thrombophlebitis (not including DVT)

136

1.40

0.66

1.4

1.2

—

75.38

—

Left bundle-branch block

1.79

0.66

1.0

1.2

—

Superficial injury of lower leg

162

1.36

0.66

1.2

1.3

—

89.83

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

1.78

0.65

1.2

—

Bacterial pneumonia, not elsewhere classified

206

0.72

0.62

1.1

1.2

—

89.36

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

1.59

0.61

1.2

1.3

—

99.48

—

Bacterial pneumonia (organism specified)

253

0.75

0.61

1.1

1.3

—

89.36

—

Car occupant injured in other and unspecified transport accidents

113

1.42

0.61

1.2

1.3

—

96.20

—

Other fall from one level to another

130

1.38

0.61

1.4

1.3

—

94.13

—

Speech therapy

151

0.66

0.59

1.0

1.3

—

87.31

—

Candidiasis, including avohilmo

210

1.29

0.58

1.3

1.2

—

87.71

—

Mycoses

176

1.31

0.56

1.3

—

88.28

—

Psoriasis

177

1.30

0.54

1.5

1.3

—

90.29

—

Other gastritis (incl. Duodenitis)

116

1.38

0.54

1.6

1.2

—

81.41

—

IBD patients in KELA-register

125

1.36

0.53

1.4

1.3

—

97.62

—

Use of levodopa decarboxylase inhibitor

1.45

0.53

1.3

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

217

1.21

0.51

1.2

—

83.78

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

118

1.36

0.50

1.5

1.2

—

85.82

—

5-aminosalicylic acid

118

1.36

0.50

1.1

1.3

—

100.08

—

Colonic or urogenital fistula

162

1.30

0.49

1.4

1.3

—

85.80

—

Herpesviral [herpes simplex] infections, including avohilmo

180

1.28

0.49

1.2

—

93.14

—

Acute pancreatitis

101

1.39

0.49

1.3

—

91.84

—

Rheumatoid arthritis, including avohilmo

243

1.23

0.49

1.3

1.2

—

85.64

—

Myocardial infarction, without ST-elevation

202

0.76

0.49

1.2

1.3

—

79.26

—

Bipolar affective disorders

111

1.35

0.46

1.1

1.3

—

102.56

—

Periapical abscess

347

1.18

0.45

1.4

1.3

—

89.86

—

Persons encountering health services in circumstances related to reproduction

324

0.85

0.45

1.4

1.3

99.15

80.24

mmol/24h

—

Basal cell carcinoma

198

1.20

0.45

1.1

1.2

—

80.25

—

Acute pancreatitis (for exclusion)

104

1.35

0.43

1.3

—

91.84

—

Adenocarcinoma of pancreas

0.00

0.41

0.0

1.3

—

Pedal cyclist injured in collision with motor vehicle

0.00

0.41

0.0

1.5

—

Other disorders of male genital organs

0.00

0.41

0.0

1.2

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

0.41

0.0

1.3

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.41

0.0

1.3

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

0.41

0.0

1.3

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.40

0.0

1.1

—

Non-Hodgkin lymphoma, all

0.00

0.40

0.0

1.2

—

Non-small cell lung cancer, squamous

0.00

0.40

0.0

1.2

—

Colorectal cancer, including Hilmo

139

0.74

0.40

1.1

1.3

—

80.62

—

Parkinson's disease, strict definition

1.31

0.39

1.1

1.2

—

Pleural plaque

1.43

0.39

1.2

—

Chronic periodontitis, complicated

400

0.85

0.39

1.3

1.2

—

86.04

—

L01XE Protein kinase inhibitors

0.00

0.39

0.0

1.2

—

Bacterial pneumoniae

218

0.80

0.39

1.2

—

87.51

—

Colorectal cancer

130

0.74

0.37

1.1

1.2

—

80.62

—

Transient ischemic attack

260

1.16

0.36

1.1

1.3

—

85.49

—

Alzheimer’s disease (Atypical or mixed)

1.41

0.35

1.3

1.2

—

Pre-eclampsia or eclampsia

144

1.25

0.35

1.2

—

89.60

—

Inflammatory bowel disease, strict (require KELA)

135

1.26

0.35

1.4

1.3

—

97.62

—

Disorders of vitreous body and globe

331

1.14

0.32

1.2

—

82.66

—

Other and unspecified disorders of vitreous body

279

1.16

0.31

1.2

—

82.66

—

Disorders of vitreous body

326

1.14

0.30

1.2

—

82.66

—

Basal cell carcinoma, including Hilmo

206

1.15

0.30

1.1

1.2

—

83.78

—

Other predominantly sexually transmitted diseases, not elsewhere classified

119

0.76

0.27

1.3

—

99.48

—

Acne

1.21

0.26

1.9

1.4

—

99.48

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

1.30

0.26

1.2

1.4

—

97.62

—

Seropositive rheumatoid arthritis

131

1.21

0.26

1.4

1.3

—

91.09

—

Obstructed labour due to malposition and malpresentation of fetus

158

0.82

0.25

1.1

1.3

—

85.12

—

Effects of foreign body entering through natural orifice

142

1.20

0.24

1.1

1.3

—

92.87

—

Other (seronegative) rheumatoid arthritis, wide

1.25

0.24

1.3

—

88.82

—

Infections with a predominantly sexual mode of transmission

221

0.86

0.23

1.2

1.3

—

83.43

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.21

0.0

1.4

—

Overjet

0.00

0.21

0.0

1.7

—

Malignant neoplasm of tonsil and base of tongue

0.00

0.21

0.0

1.4

—

Anomalies of pupillary function

0.00

0.21

0.0

1.2

—

Malignant neoplasm of small intestine

0.00

0.21

0.0

1.3

—

Viral conjunctivitis

0.00

0.21

0.0

1.2

—

Retinoschisis and retinal cysts

0.00

0.21

0.0

1.2

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

0.00

0.21

0.0

1.4

—

Acute myeloid leukaemia and myelodysplastic syndromes

0.00

0.21

0.0

1.2

—

Benign neoplasm: other/unspecified salivary gland

0.00

0.21

0.0

1.3

—

Myeloid leukaemia

0.00

0.21

0.0

1.3

—

Disorders of acoustic nerve

0.00

0.21

0.0

1.2

—

Small cell lung cancer, helper endpoint

0.00

0.21

0.0

1.3

—

Pre-eclampsia

135

1.19

0.21

1.2

—

89.60

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

0.21

0.0

1.3

—

Aggressive periodontitis

0.00

0.21

0.0

1.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

0.00

0.21

0.0

1.3

—

Multiple myeloma

0.00

0.21

0.0

1.3

—

Hodgkin lymphoma, hilmo

0.00

0.21

0.0

1.2

—

Malignant neoplasm of small intestine, including Hilmo

0.00

0.21

0.0

1.3

—

Renal cell carcinoma of kidney

0.00

0.21

0.0

1.3

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

0.21

0.0

1.3

—

Other specified and unspecified retinal disorders

0.00

0.21

0.0

1.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

123

0.81

0.20

1.3

1.2

—

89.82

—

Myelodysplastic syndrome, including Hilmo

0.00

0.20

0.0

1.2

—

Alzheimer’s disease (Early onset)

0.00

0.20

0.0

1.3

—

Transient global amnesia

1.25

0.20

1.0

1.2

—

Coxarthrosis, primary, with hip surgery

258

1.11

0.19

1.2

—

92.55

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

193

1.14

0.19

1.4

1.3

—

92.73

—

Eating disorder

1.17

0.19

1.3

1.4

—

99.48

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

139

0.84

0.19

1.1

1.2

—

80.62

—

Sequelae of cerebrovascular disease

174

1.13

0.18

1.2

1.3

—

92.87

—

Eating disorders

1.13

0.17

1.7

1.3

—

99.48

—

Other viral diseases

195

1.12

0.16

1.2

1.3

—

87.70

—

Alcohol abuse, main dg

1.20

0.16

1.5

1.3

—

91.84

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.20

0.16

1.2

1.3

—

97.62

—

Liquid cancers, including Hilmo

198

0.89

0.15

1.2

—

80.62

—

Injury of eye and orbit

1.15

0.15

1.1

1.3

—

91.84

—

Anomalies of dental arch relationship, including avohilmo

110

1.15

0.14

1.5

1.3

—

97.62

—

Other strabismus

127

0.86

0.13

1.1

1.3

—

94.32

—

Striking against or struck by other objects

228

1.09

0.13

1.3

—

95.44

—

Other disorders of bone

123

1.14

0.12

1.0

1.3

—

91.84

—

Pediculosis, acariasis and other infestations, including avohilmo

104

1.15

0.12

1.4

1.3

—

97.62

—

Complications predominantly related to the puerperium

179

0.89

0.12

1.3

1.2

—

84.37

—

Nonsuppurative otitis media

132

1.12

0.11

1.4

1.3

—

90.85

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

147

0.88

0.11

1.3

—

90.85

—

Fall on and from stairs and steps

153

1.11

0.11

1.5

1.2

—

87.63

—

Strabismus

153

1.11

0.10

1.2

—

91.97

—

COPD-related respiratory insufficiency

1.09

0.09

1.0

1.2

—

Haemorrhage in early pregnancy

197

1.08

0.09

1.5

1.3

—

83.77

—

Organic, including symptomatic, mental disorders

225

0.94

0.09

1.4

1.2

—

86.59

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

145

1.10

0.09

1.4

1.2

—

84.96

—

Covid-19 suspected case

134

0.90

0.08

1.2

—

96.20

—

1.03

0.08

1.3

—

99.48

—

Other/unspecified seropositive rheumatoid arthritis

146

1.10

0.08

1.4

1.2

—

84.96

—

Scabies, including avohilmo

1.14

0.08

1.4

1.2

—

97.62

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.03

0.07

1.6

1.3

—

99.48

—

Emotionally unstable personality disorder

1.08

0.07

1.0

1.3

—

99.48

—

Dementia in Alzheimer disease

1.03

0.07

1.6

1.2

—

Seropositive rheumatoid arthritis, wide

147

1.09

0.07

1.4

1.2

—

84.96

—

Superficial injury of head

138

1.09

0.06

1.2

1.3

—

87.63

—

Myocardial infarction

206

0.95

0.06

1.3

1.2

—

85.49

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

109

1.10

0.06

1.2

1.3

—

97.62

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

109

1.10

0.06

1.2

—

81.41

—

Unspecified mental disorder

287

1.04

0.05

1.3

—

90.94

—

Special screening examination for infectious and parasitic diseases

131

0.95

0.03

1.1

1.4

—

79.31

—

Acute alcohol intoxication

151

1.06

0.03

1.4

1.3

—

95.49

—

Myocardial infarction, strict

184

0.96

0.03

1.3

1.2

—

85.49

—

Fracture of lumbar spine and pelvis

118

0.93

0.03

1.2

1.3

—

89.82

—

Ulcerative colitis (strict definition, require KELA)

103

1.07

0.02

1.2

1.3

—

97.62

—

Acute alcohol intoxication, ICD10

123

1.06

0.01

1.5

1.3

—

92.87

—

Kela-code for severe mental illness

253

1.03

0.01

1.3

—

90.94

—

Infections with a predominantly sexual mode of transmission, including avohilmo

277

1.02

0.01

1.3

—

82.47

—

Abnormal findings on diagnostic imaging of lung

278

1.02

0.01

1.2

—

84.75

—

Liquid cancers

160

1.01

0.00

1.2

1.3

—

80.62

—

Dermatophytosis, including avohilmo

504

1.01

0.00

1.3

—

80.94

—

Fitting and adjustment of other devices

198

0.98

0.00

1.2

—

77.78

—

Injury of muscle and tendon at shoulder and upper arm level

229

1.00

0.00

1.2

—

88.85

—

Abnormal serum enzyme levels

167

0.98

0.00

1.2

1.3

—

92.87

—

Acne, including avohilmo

124

0.98

0.00

1.5

1.3

—

83.95

—

Discitis, unspecified

0.00

0.0

1.0

—

Malignant neoplasm of eye and adnexa, including Hilmo

0.00

0.0

1.1

—

Small cell lung cancer

0.00

0.0

1.2

—

Marginal zone B-cell lymphoma

0.00

0.0

1.2

—

Trichomoniasis

0.00

0.0

1.2

—

Ankle and foot

0.00

0.0

1.4

—

Small cell lung cancer, including Hilmo

0.00

0.0

1.2

—

Malignant neoplasm of tonsil

0.00

0.0

1.2

—

Pneumoconiosis due to asbestos and other mineral fibres

0.00

0.0

1.2

—

Alcohol abuse counselling and surveillance

0.00

0.0

1.3

—

Secondary malignant neoplasm of respiratory and digestive organs

0.00

0.0

1.3

—

LSIL lesion of the cervix uteri, vagina or vulva

0.95

0.00

1.1

1.3

—

99.48

—

Amputation of ankle bones

0.00

0.0

1.3

—

Chronic myeloproliferative disease

0.00

0.0

1.0

—

Malignant neoplasm of parotid gland, including Hilmo

0.00

0.0

1.3

—

Hypothyroidism due to medicaments and other exogenous substances

0.00

0.0

1.2

—

Early syphilis

0.00

0.0

1.0

—

Malignant neoplasm of oropharynx

0.00

0.0

1.2

—

Unattended death

0.00

0.0

1.2

—

Malignant neoplasm of tonsil, including Hilmo

0.00

0.0

1.2

—

Malignant neoplasm of other and unspecified female genital organs

0.00

-0.00

0.0

1.3

—

Mesothelioma, including Hilmo

0.00

-0.00

0.0

1.4

—

Other abnormal auditory perceptions

0.00

-0.00

0.0

1.3

—

Monoplegia

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

0.00

-0.00

0.0

1.2

—

Leiomyosarcoma, including Hilmo

0.00

-0.00

0.0

1.3

—

Other bursitis of knee

0.00

-0.00

0.0

1.1

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

0.00

-0.00

0.0

1.2

—

Neuroendocrine tumor and carcinoma of small intestine

0.00

-0.00

0.0

1.3

—

Helminthiases

0.00

-0.00

0.0

1.4

—

Injury of nerves at shoulder and upper arm level

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of anus and anal canal, including Hilmo

0.00

-0.00

0.0

1.3

—

Gastrointestinal stromal tumor and sarcoma

0.00

-0.00

0.0

1.4

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

0.00

-0.00

0.0

1.3

—

Amputation of thigh

0.00

-0.00

0.0

1.3

—

Neuroendocrine tumor and carcinoma of lung

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of larynx, including Hilmo

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of renal pelvis, including Hilmo

0.00

-0.00

0.0

1.2

—

Guillain-Barre syndrome

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

0.00

-0.00

0.0

1.4

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

0.00

-0.00

0.0

1.3

—

Trichomoniasis, including avohilmo

0.00

-0.00

0.0

1.2

—

Hereditary ataxia

0.00

-0.00

0.0

1.2

—

Other sexually transmitted chlamydial diseases, including avohilmo

1.00

-0.00

1.1

1.4

—

79.37

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

0.00

-0.00

0.0

1.4

—

Other diseases of appendix

0.00

-0.00

0.0

1.2

—

Hypertrophy of tongue papillae

0.00

-0.00

0.0

1.2

—

Androgenic alopecia

0.00

-0.00

0.0

1.4

—

Corneal degeneration

0.00

-0.00

0.0

1.1

—

Portal vein thrombosis

0.00

-0.00

0.0

1.1

—

Synovial hypertrophy, not elsewhere classified

0.00

-0.00

0.0

1.3

—

Colon adenocarcinoma, helper endpoint

0.89

-0.00

1.0

1.3

—

Inflammation of lacrimal passages (chronic)

0.00

-0.00

0.0

1.2

—

Osteonecrosis due to drugs

0.00

-0.00

0.0

1.0

—

Communicating hydrocephalus

0.00

-0.00

0.0

1.1

—

Encephalopathy

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of palate, including Hilmo

0.00

-0.00

0.0

1.2

—

Crystal arthropathies, rheuma endpoint

0.00

-0.00

0.0

1.4

—

Superficial injury of neck

0.00

-0.00

0.0

1.2

—

Other and unspecified haemorrhagic conditions

0.00

-0.00

0.0

1.0

—

LSIL lesion of the cervix uteri

0.87

-0.00

1.0

1.3

—

99.48

—

Carcinoma in situ of rectum

0.00

-0.00

0.0

1.1

—

Endometriosis of intestine

0.00

-0.00

0.0

2.8

—

Injury of nerves at lower leg level

0.00

-0.00

0.0

1.4

—

Melanocytic naevi of upper limb, including shoulder

0.00

-0.00

0.0

1.3

—

Embolic stroke with flimmer

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of parotid gland

0.00

-0.00

0.0

1.3

—

Other and specified injuries of hip and thigh

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Appendix

0.00

-0.00

0.0

1.4

—

Pulmonary eosinophilia, not elsewhere classified

0.00

-0.00

0.0

1.3

—

Alcoholic gastritis

0.00

-0.00

0.0

1.3

—

Endometroid carcinoma of ovary

0.00

-0.00

0.0

1.2

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

-0.00

0.0

1.2

—

Pyogenic granuloma

0.00

-0.00

0.0

1.4

—

Accidental poisoning by and exposure to alcohol

0.00

-0.00

0.0

1.2

—

Contact with lifting and transmission devices, not elsewhere classified

0.00

-0.00

0.0

1.3

—

Marginal zone B-cell lymphoma, including Hilmo

0.00

-0.00

0.0

1.2

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

0.00

-0.00

0.0

1.4

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Other and unspecified parts of small intestine

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Brain, supratentorial

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of larynx

0.00

-0.00

0.0

1.2

—

Secondary malignant neoplasm of other and unspecified sites

0.00

-0.00

0.0

1.3

—

Carcinoma in situ of skin of lower limb, including hip

0.00

-0.00

0.0

1.2

—

Donors of organs and tissues

0.00

-0.00

0.0

1.4

—

Shoulder region

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of gum, including Hilmo

0.00

-0.00

0.0

1.3

—

Hereditary motor and sensory neuropathy

0.00

-0.00

0.0

1.4

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

0.00

-0.00

0.0

1.2

—

Colorectal neuroendocrine tumor and carcinoma

0.00

-0.00

0.0

1.3

—

Congenital deformities of hip

0.00

-0.00

0.0

1.4

—

Other melanin hyperpigmentation

0.00

-0.00

0.0

1.3

—

Early syphilis, including avohilmo

0.00

-0.00

0.0

1.0

—

Other infestations, including avohilmo

0.00

-0.00

0.0

1.3

—

Keratoconus

0.00

-0.00

0.0

1.3

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Potassium [Moles/time] in 24 hour Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS